Literature DB >> 1572983

Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest U.S. epidemic of sporotrichosis.

D M Dixon1, R A Duncan, N J Hurd.   

Abstract

Five clinical and 69 environmental isolates from the largest U.S. epidemic of sporotrichosis were evaluated in NYLAR male mice following intravenous injection of 5 x 10(6) to 2 x 10(8) conidia per mouse. The clinical isolates and eight environmental isolates produced 100% mortality in groups of three mice each between 12 and 24 days after injection. These virulent isolates grew at 37 degrees C, were dematiaceous by virtue of melanin (melanized) on permissive media (e.g., potato dextrose agar), produced ovoid conidia borne sympodially on lateral conidiophores and pleurogenously about the main hyphal axis, and were identified as Sporothrix schenckii. Two melanized environmental isolates that grew at 35 degrees C but not at 37 degrees C were not virulent and had subtle morphological differences from S. schenckii. The remaining environmental isolates were not melanized, were not virulent, and were not S. schenckii; five were identified as Ophiostoma stenoceras and the remainder were identified as Sporothrix spp. Quantitative organ cultures revealed that clinical isolates grew exponentially in livers and testes, in contrast to an isolate of O. stenoceras that was eliminated from liver, lung, and spleen but that persisted in the testes throughout the 14-day sample period. This model helped to confirm the identification of S. schenckii isolates obtained from the environment.

Entities:  

Mesh:

Year:  1992        PMID: 1572983      PMCID: PMC265192          DOI: 10.1128/jcm.30.4.951-954.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Treatment of experimental sporotrichosis in mice with griseofulvin and amphotericin B.

Authors:  E TSUBURA; J SCHWARZ
Journal:  Antibiot Chemother (Northfield)       Date:  1960-12

2.  Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans.

Authors:  T J Walsh; C McEntee; D M Dixon
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

3.  Studies in sporotrichosis: fungal morphogenesis and pathogenicity in differing environments.

Authors:  G H Findlay; H F Vismer
Journal:  Mycopathologia       Date:  1986-11       Impact factor: 2.574

4.  A comparison of some Ceratocystis species with Sporothrix schenckii.

Authors:  J J Taylor
Journal:  Mycopathol Mycol Appl       Date:  1970-12-29

5.  Defensive role of granuloma against Sporothrix schenckii infection.

Authors:  M Miyaji; K Nishimura
Journal:  Mycopathologia       Date:  1982-11-19       Impact factor: 2.574

6.  Mel- mutants of Wangiella dermatitidis in mice: evaluation of multiple mouse and fungal strains.

Authors:  D M Dixon; A Polak; G W Conner
Journal:  J Med Vet Mycol       Date:  1989

7.  Pathogenicity and virulence of wild-type and melanin-deficient Wangiella dermatitidis.

Authors:  D M Dixon; A Polak; P J Szaniszlo
Journal:  J Med Vet Mycol       Date:  1987-04

8.  Increased resistance of splenectomized mice to Sporothrix schenckii infection.

Authors:  M Miyaji; K Nishimura
Journal:  Mycopathologia       Date:  1986-12       Impact factor: 2.574

9.  Susceptibility of congenitally athymic (nude) mice to sporotrichosis.

Authors:  C L Dickerson; R L Taylor; D J Drutz
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Efficacies of four antifungal agents in experimental murine sporotrichosis.

Authors:  V L Kan; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

View more
  8 in total

1.  Detection of Sporothrix schenckii in clinical samples by a nested PCR assay.

Authors:  Sindy Hu; Wen-Hung Chung; Shuen-Iu Hung; Hsin-Chun Ho; Zen-Whe Wang; Chien-Hsun Chen; Shu-Chuan Lu; Tseng-Tong Kuo; Hong-Shang Hong
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Differences in virulence between isolates of feline Sporotrichosis.

Authors:  Márcia de Oliveira Nobre; Tatiana de Avila Antunes; Renata Osório de Faria; Marlete Brum Cleff; Cristina Gevehr Fernandes; Adriana Cunha Muschner; Mário Carlos Araújo Meireles; Laerte Ferreiro
Journal:  Mycopathologia       Date:  2005-08       Impact factor: 2.574

Review 3.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Sporotrichosis caused by Sporothrix globosa in Rio De Janeiro, brazil: case report.

Authors:  Manoel Marques Evangelista de Oliveira; Rodrigo de Almeida-Paes; Mauro de Medeiros Muniz; Monica Bastos de Lima Barros; Maria Clara Gutierrez Galhardo; Rosely Maria Zancope-Oliveira
Journal:  Mycopathologia       Date:  2010-02-04       Impact factor: 2.574

5.  DNA typing of isolates associated with the 1988 sporotrichosis epidemic.

Authors:  C R Cooper; B J Breslin; D M Dixon; I F Salkin
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  What lies beyond genetic diversity in Sporothrix schenckii species complex?: New insights into virulence profiles, immunogenicity and protein secretion in S. schenckii sensu stricto isolates.

Authors:  Orazio Romeo; Giuseppe Criseo
Journal:  Virulence       Date:  2013-01-18       Impact factor: 5.882

7.  Efficacy of posaconazole in murine experimental sporotrichosis.

Authors:  Fabiola Fernández-Silva; Javier Capilla; Emilio Mayayo; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

8.  Evidence for growth of Sporothrix schenckii on dead but not on living sphagnum moss.

Authors:  X Zhang; J H Andrews
Journal:  Mycopathologia       Date:  1993-08       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.